The role of G protein B subunits in the release of ATP from human erythrocytes

被引:0
|
作者
Sprague, RS [1 ]
Bowles, EA [1 ]
Olearczyk, JJ [1 ]
Stephenson, AH [1 ]
Lonigro, AJ [1 ]
机构
[1] St Louis Univ, Sch Med, St Louis, MO 63104 USA
来源
关键词
red blood cell; mastoparin; adenylyl cyclase;
D O I
暂无
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Previously, we demonstrated that adenosine triphosphate (ATP) is released from human erythrocytes in response to mechanical deformation and that this release requires activation of a signal-transduction pathway involving adenylyl cyclase and the heterotrimeric G protein, Gs. Here we investigate the role of heterotrimeric G proteins of the Gi subtype in the release of ATP from human erythrocytes. In addition, we,,e determined the profile of heterotrimeric G protein submits present in these erythrocyte membranes. The activity of Gi was stimulated by incubation of erythrocytes (20% hematocrit) with mastoparin (10 muM). ATP release was measured using the luciferin/luciferase assay. Heterotrimeric G protein beta subunits present in erythrocyte membranes were resolved using gel electrophoresis and subunit specific antibodies. Incubation of human erythrocytes with mastoparan (an activator ofGi/o) resulted in a 4.1 +/- 0.6-fold increase in ATP present in the medium (P<0.01). Human erythrocyte membranes stain positively for P subunit types 1, 2, 3 and 4, all of which been reported to activate of some isoforms of adenylyl cyclase. Activation of the heterotrimeric G protein. Gi, results in ATP release from erythrocytes. This effect is may be related to the activity Of P submits associated with this G protein in the human erythrocyte.
引用
收藏
页码:667 / 674
页数:8
相关论文
共 50 条
  • [1] ATP release from erythrocytes: A role of adenosine
    Misiti, Francesco
    Carelli-Alinovi, Cristiana
    Rodio, Angelo
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2022, 80 (02) : 61 - 71
  • [2] Insulin inhibits ATP release from human erythrocytes
    Stumpf, M
    Stephenson, A
    Bowles, E
    Ricketts, G
    Lonigro, A
    Sprague, R
    FASEB JOURNAL, 2006, 20 (04): : A269 - A269
  • [3] Heterotrimeric G protein Gi is involved in a signal transduction pathway for ATP release from erythrocytes
    Olearczyk, JJ
    Stephenson, AH
    Lonigro, AJ
    Sprague, RS
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2004, 286 (03): : H940 - H945
  • [4] Inhibition of ATP Release from Erythrocytes: A Role for EPACs and PKC
    Adderley, Shaquria P.
    Sridharan, Meera
    Bowles, Elizabeth A.
    Stephenson, Alan H.
    Sprague, Randy S.
    Ellsworth, Mary L.
    MICROCIRCULATION, 2011, 18 (02) : 128 - 135
  • [5] Amyloid peptide inhibits ATP release from human erythrocytes
    Misiti, Francesco
    Orsini, Federica
    Clementi, M. Elisabetta
    Masala, Daniele
    Tellone, Ester
    Galtieri, Antonio
    Giardina, Bruno
    BIOCHEMISTRY AND CELL BIOLOGY, 2008, 86 (06) : 501 - 508
  • [6] Expression of the heterotrimeric G protein Gi and ATP release are impaired in erythrocytes of humans with diabetes mellitus
    Sprague, Randy
    Stephenson, Alan
    Bowles, Elizabeth
    Stumpf, Madelyn
    Ricketts, Gregory
    Lonigro, Andrew
    HYPOXIA AND EXERCISE, 2006, 588 : 207 - 216
  • [7] NO inhibits signal transduction pathway for ATP release from erythrocytes via its action on heterotrimeric G protein Gi
    Olearczyk, JJ
    Stephenson, AH
    Lonigro, AJ
    Sprague, RS
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2004, 287 (02): : H748 - H754
  • [8] ATP release in human erythrocytes-is hemolysis a primary release mechanism?
    Grygorczyk, Ryszard
    Sikora, Jacek
    Orlov, Sergei N.
    Furuya, Kishio
    PURINERGIC SIGNALLING, 2014, 10 (04) : 787 - 787
  • [9] RELEASE OF ATP FROM HUMAN ERYTHROCYTES IN RESPONSE TO A BRIEF PERIOD OF HYPOXIA AND HYPERCAPNIA
    BERGFELD, GR
    FORRESTER, T
    CARDIOVASCULAR RESEARCH, 1992, 26 (01) : 40 - 47
  • [10] Nitric oxide inhibits ATP release from erythrocytes
    Olearczyk, JJ
    Ellsworth, ML
    Stephenson, AH
    Lonigro, AJ
    Sprague, RS
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 309 (03): : 1079 - 1084